The Xen45 gel stent is a viable option after failed trabeculectomy and has the same good results as primary implantation in terms of IOP-lowering effect and independence from glaucoma medications, according to a study.
When trabeculectomy fails, a second attempt with the same procedure leads to poorer outcomes, and often glaucoma drainage devices have been used. The Xen45 gel stent (Allergan) is a latest-generation drainage device with a smaller lumen, requiring a less invasive ab interno implantation technique. The use of Xen after failed trabeculectomy is not new, but no (Read more...)
Uncategorized